Xiaoyang Chu

873 total citations
25 papers, 614 citations indexed

About

Xiaoyang Chu is a scholar working on Molecular Biology, Biomaterials and Genetics. According to data from OpenAlex, Xiaoyang Chu has authored 25 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Biomaterials and 4 papers in Genetics. Recurrent topics in Xiaoyang Chu's work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (4 papers) and Extracellular vesicles in disease (3 papers). Xiaoyang Chu is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (4 papers) and Extracellular vesicles in disease (3 papers). Xiaoyang Chu collaborates with scholars based in China, United States and Portugal. Xiaoyang Chu's co-authors include Chunsheng Gao, Lin Cui, Shiyao Fu, Wei Gong, Yang Yang, Meiyan Yang, Yi Li, Baoshan Sun, Han Yang and Chunhong Gao and has published in prestigious journals such as ACS Applied Materials & Interfaces, Molecules and International Journal of Pharmaceutics.

In The Last Decade

Xiaoyang Chu

25 papers receiving 608 citations

Peers

Xiaoyang Chu
Xiaoyang Chu
Citations per year, relative to Xiaoyang Chu Xiaoyang Chu (= 1×) peers Bruna dos Santos Rodrigues

Countries citing papers authored by Xiaoyang Chu

Since Specialization
Citations

This map shows the geographic impact of Xiaoyang Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyang Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyang Chu more than expected).

Fields of papers citing papers by Xiaoyang Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyang Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyang Chu. The network helps show where Xiaoyang Chu may publish in the future.

Co-authorship network of co-authors of Xiaoyang Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyang Chu. A scholar is included among the top collaborators of Xiaoyang Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyang Chu. Xiaoyang Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chu, Xiaoyang. (2024). Analysis of EEG characteristics in Alzheimer’s disease. 1(6). 1 indexed citations
4.
Yang, Kai, Xiaoyang Chu, Jing Zhang, et al.. (2023). Assessment of a novel variation in DHODH gene causing Miller syndrome: The first report in Chinese population. Molecular Genetics & Genomic Medicine. 11(7). e2186–e2186. 2 indexed citations
5.
Wang, Hao, Qing Yao, Wenquan Zhu, et al.. (2022). Biomimetic Antidote Nanoparticles: a Novel Strategy for Chronic Heavy Metal Poisoning. AAPS PharmSciTech. 24(1). 12–12. 6 indexed citations
6.
Zheng, Chunyan, Xiaoyang Chu, Chunyan Gao, et al.. (2022). TAT&RGD Peptide-Modified Naringin-Loaded Lipid Nanoparticles Promote the Osteogenic Differentiation of Human Dental Pulp Stem Cells. International Journal of Nanomedicine. Volume 17. 3269–3286. 8 indexed citations
7.
Chu, Xiaoyang, et al.. (2022). Asiaticoside Enhances the Osteoblast Potential of LPS-induced PeriodontalLigament Stem Cells through TLR4/NF-κB Pathway. Letters in Drug Design & Discovery. 20(7). 838–844. 1 indexed citations
8.
Chen, Xu, Chunyan Gao, Xiaoyang Chu, et al.. (2022). VEGF-Loaded Heparinised Gelatine-Hydroxyapatite-Tricalcium Phosphate Scaffold Accelerates Bone Regeneration via Enhancing Osteogenesis-Angiogenesis Coupling. Frontiers in Bioengineering and Biotechnology. 10. 915181–915181. 22 indexed citations
9.
Chu, Xiaoyang, et al.. (2022). Betanin alleviates inflammation and ameliorates apoptosis on human oral squamous cancer cells SCC131 and SCC4 through the NF‐κB/PI3K/Akt signaling pathway. Journal of Biochemical and Molecular Toxicology. 36(8). e23094–e23094. 7 indexed citations
10.
He, Xin, Zhan Yang, Xiaoyang Chu, et al.. (2022). ROR2 Downregulation Activates the MSX2/NSUN2/p21 Regulatory Axis and Promotes Dental Pulp Stem Cell Senescence. Stem Cells. 40(3). 290–302. 12 indexed citations
11.
Meng, Yuanyuan, et al.. (2021). Cepharanthine loaded nanoparticles coated with macrophage membranes for lung inflammation therapy. Drug Delivery. 28(1). 2582–2593. 28 indexed citations
12.
Lu, Rongjian, et al.. (2020). Antibacterial peptides inhibit MC3T3-E1 cells apoptosis induced by TNF-α through p38 MAPK pathway. Annals of Translational Medicine. 8(15). 943–943. 10 indexed citations
13.
Gao, Chunhong, Wei Gong, Meiyan Yang, et al.. (2020). T807-modified human serum albumin biomimetic nanoparticles for targeted drug delivery across the blood–brain barrier. Journal of drug targeting. 28(10). 1085–1095. 10 indexed citations
14.
Meng, Lingwei, Xiaoyang Chu, Xuan Liu, et al.. (2019). Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol. International Journal of Pharmaceutics. 567. 118485–118485. 45 indexed citations
15.
Chu, Xiaoyang, Wei Huang, Yuli Wang, et al.. (2019). <p>Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin&ndash;chitosan nanoparticles loading paclitaxel&ndash;cholesterol complex</p>. International Journal of Nanomedicine. Volume 14. 689–705. 48 indexed citations
16.
Chen, Lu, Xiaoyang Chu, Chun‐Hong Gao, et al.. (2019). Polymer Distribution and Mechanism Conversion in Multiple Media of Phase-Separated Controlled-Release Film-Coating. Pharmaceutics. 11(2). 80–80. 14 indexed citations
17.
Han, Ying, Liqing Chen, Wei Liu, et al.. (2019). An HPLC–MS/MS Method for Quantitation of Trelagliptin and Application in a Comparative Pharmacokinetic Study. Bioanalysis. 11(19). 1755–1765. 1 indexed citations
18.
Wang, Yuli, Meiyan Yang, Jiahui Yang, et al.. (2018). Systematic Development of Self-Nanoemulsifying Liquisolid Tablets to Improve the Dissolution and Oral Bioavailability of an Oily Drug, Vitamin K1. Pharmaceutics. 10(3). 96–96. 18 indexed citations
19.
Fu, Shiyao, Meng Liang, Yuli Wang, et al.. (2018). Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma. ACS Applied Materials & Interfaces. 11(2). 1841–1854. 135 indexed citations
20.
Cui, Lin, Yuli Wang, Meng Liang, et al.. (2018). Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery. Drug Delivery. 25(1). 1865–1876. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026